Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssetco Regulatory News (ASTO)

  • There is currently no data for ASTO

Completion of acquisition

30 Jul 2021 08:00

RNS Number : 0493H
AssetCo PLC
30 July 2021
 

30 July 2021

AssetCo plc

("AssetCo" or the "Company")

Completion of acquisition of Saracen Fund Managers Limited

On 14 May 2021, the Company announced that it had reached agreement to acquire the entire issued share capital of Saracen Fund Managers Limited ("Saracen") (the "Acquisition") for an effective total consideration of £2.75 million (the "Consideration"). The Acquisition was conditional on, inter alia, approval by the FCA to the change of controller and the admission of the Consideration Shares to trading on AIM. The Consideration for the Acquisition was to be satisfied by the issue of 166,904 new ordinary shares of 10p each in the Company, fully paid (the "Consideration Shares") and £664,774 in cash.

 

The Company is pleased to announce that the conditions pertaining to the Acquisition have been satisfied and that completion of the Acquisition took place earlier today.

 

The Acquisition follows on from the completion of the acquisition of an effective 63% equity interest in ETF Rize Limited from J&E Davy Holdings, which took place on 27 July.

 

Peter McKellar, Deputy Chairman and CEO of AssetCo, commented:

 

"The completion of the acquisition of Saracen Fund Managers is part of AssetCo's overall strategy of investing in, building and managing asset and wealth management businesses. Saracen is a small fund management firm with great potential. Our aim is to grow the business through marketing its existing funds and, over time, broadening its product range to meet the evolving needs of investors.

 

"The acquisition of Saracen, alongside the completion of the acquisition of a majority equity interest in Rize ETF, comes a little over three months since AssetCo's new strategy was approved by shareholders. There are numerous structural shifts taking place within the asset and wealth management industry, including demographics and the use of technology. These are presenting challenges and opportunities for incumbent firms. Without the constraints of a legacy business, we believe we can capitalise on these shifts to generate significant value and to deliver successful outcomes for clients and shareholders."

Enquiries:

AssetCo plc

Peter McKellar, Deputy Chairman and CEO

James Thorneley, Head of Communications

Tel: +44 (0) 7958 005 141

 

Arden Partners plc

Nominated adviser and broker

John Llewellyn-Lloyd / Louisa Waddell / Akhil Shah

Tel: +44 (0) 20 7614 5900

 

Maitland/AMO

Neil Bennett

Rachel Cohen

Tel: +44 (207) 379 5151

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQZZGFNVGRGMZG
Date   Source Headline
15th Dec 20224:32 pmRNSTransaction in Own Shares
13th Dec 20224:29 pmRNSTransaction in Own Shares
13th Dec 20227:00 amRNSTransaction in Own Shares
7th Dec 20224:25 pmRNSChange of Registered Office
29th Nov 202211:06 amRNSDividend Declaration - Replacement
28th Nov 20224:42 pmRNSHolding(s) in Company
24th Nov 20224:50 pmRNSTransaction in Own Shares
24th Nov 20224:43 pmRNSInterim Dividend Declaration
23rd Nov 20224:47 pmRNSTransaction in Own Shares
22nd Nov 20224:48 pmRNSTransaction in Own Shares
11th Nov 20229:33 amRNSTransaction in Own Shares
9th Nov 20225:54 pmRNSTransaction in Own Shares
9th Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20221:47 pmRNSHolding(s) in Company
1st Nov 20222:56 pmRNSTransaction in Own Shares
1st Nov 20221:25 pmRNSNotification of major holdings
1st Nov 202212:07 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSCompletion of acquisition of SVM Asset Management
31st Oct 20225:36 pmRNSTransaction in Own Shares
27th Oct 202210:23 amRNSHolding(s) in Company
25th Oct 20224:17 pmRNSTransaction in Own Shares
24th Oct 20223:23 pmRNSDirector/PDMR Shareholding
21st Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20224:11 pmRNSTransaction in Own Shares
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
12th Oct 20225:04 pmRNSTransaction in Own Shares
12th Oct 20227:00 amRNSAcceleration of £7.5m Share Repurchase Programme
11th Oct 20223:21 pmRNSDirectorate Change
11th Oct 202212:29 pmRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
7th Oct 20224:19 pmRNSTransaction in Own Shares
6th Oct 20224:26 pmRNSTransaction in Own Shares
5th Oct 20225:13 pmRNSTransaction in Own Shares
4th Oct 20225:43 pmRNSTransaction in Own Shares
3rd Oct 20225:10 pmRNSTransaction in Own Shares
3rd Oct 20224:18 pmRNSDirector/PDMR Shareholding
30th Sep 20225:13 pmRNSTransaction in Own Shares
29th Sep 20226:37 pmRNSTransaction in Own Shares
29th Sep 20227:00 amRNSShare Repurchase Programme & Results of Meeting
12th Sep 20227:00 amRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSAuthority to repurchase shares & notice of meeting
8th Sep 20222:05 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSStatement regarding Parmenion Capital Partners LLP
2nd Sep 20223:53 pmRNSTotal Voting Rights
12th Aug 20229:49 amRNSPDMR/PCA Shareholding
10th Aug 202212:45 pmRNSResults of General Meeting
8th Aug 20228:00 amRNSCompletion of the sale of R&M LLC for $8.79m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.